Literature DB >> 11091051

Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy.

M Bassetti1, A Di Biagio, B Rebesco, G Cenderello, M E Amalfitano, D Bassetti.   

Abstract

We have analysed the expenditure on antimicrobial drugs in the largest hospital in Italy; over this period, a committee prepared an antibiotic policy document. This formulary lists all antimicrobial drugs available in the hospital. Some drugs were removed from the list and others are only available on special request for a named patient. In the hope of optimising drug utilisation, we included all the reasons for the choice of agent in the document. The introduction of this formulary resulted in an immediate saving and perhaps in the future we shall also observe an improvement in bacterial resistance patterns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091051     DOI: 10.1016/s0924-8579(00)00249-1

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  10 in total

1.  Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in Slovenia.

Authors:  Jure Peklar; Franci Tratar; Ales Mrhar
Journal:  Pharm World Sci       Date:  2004-12

2.  The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis.

Authors:  Israel Rico-Alba; Albert Figueras
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

3.  The impact of an intensive antimicrobial control program in a Taiwanese medical center.

Authors:  Ming-Tsung Chang; Tzu-Hua Wu; Chun-Yu Wang; Tsrang-Neng Jang; Chien-Yu Huang
Journal:  Pharm World Sci       Date:  2006-10-26

4.  A Comparative Analysis of Public Hospital Pharmacy Systems in Norway and Pakistan: A Pilot Implementation of the American Society of Health-System Pharmacists' (ASHP) Guidelines.

Authors:  Bilal Hasan Hashmi; Adnan Kisa
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

5.  The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.

Authors:  Adalet Altunsoy; Cenk Aypak; Alpay Azap; Önder Ergönül; Ismail Balık
Journal:  Int J Med Sci       Date:  2011-05-24       Impact factor: 3.738

6.  Inappropriately prescribed and over-the-counter antimicrobials in the Brazilian Amazon Basin: We need to promote more rational use even in remote places.

Authors:  Abel Santiago Muri-Gama; Albert Figueras; Silvia Regina Secoli
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

7.  Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.

Authors:  Yuan-Ti Lee; Shih-Ming Tsao; Hui-Chih Lin; Huey-Jen Huang; Meng-Chih Lee; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2010-09-19       Impact factor: 5.283

8.  Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China.

Authors:  Dapeng Hou; Qiushi Wang; Cuihua Jiang; Cui Tian; Huaqing Li; Bo Ji
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

Review 9.  A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals.

Authors:  Mary Richard Akpan; Raheelah Ahmad; Nada Atef Shebl; Diane Ashiru-Oredope
Journal:  Antibiotics (Basel)       Date:  2016-01-13

10.  De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT).

Authors:  Ted A Skolarus; Sarah T Hawley; Daniela A Wittmann; Jane Forman; Tabitha Metreger; Jordan B Sparks; Kevin Zhu; Megan E V Caram; Brent K Hollenbeck; Danil V Makarov; John T Leppert; Jeremy B Shelton; Vahakn Shahinian; Sriram Srinivasaraghavan; Anne E Sales
Journal:  Implement Sci       Date:  2018-11-29       Impact factor: 7.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.